✦ LIBER ✦
Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial
✍ Scribed by van Meurs, Hannah S.; Tajik, Parvin; Hof, Michel H.P.; Vergote, Ignace; Kenter, Gemma G.; Mol, Ben Willem J.; Buist, Marrije R.; Bossuyt, Patrick M.
- Book ID
- 121222043
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 712 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.